384 related articles for article (PubMed ID: 25939817)
1. Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?
Müller-Deile J; Schiffer M
Pediatr Nephrol; 2016 Mar; 31(3):393-405. PubMed ID: 25939817
[TBL] [Abstract][Full Text] [Related]
2. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of research on the podocyte slit diaphragm.
Johnstone DB; Holzman LB
Nat Clin Pract Nephrol; 2006 May; 2(5):271-82. PubMed ID: 16932440
[TBL] [Abstract][Full Text] [Related]
4. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
[TBL] [Abstract][Full Text] [Related]
5. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
[TBL] [Abstract][Full Text] [Related]
6. Podocyte injury and targeting therapy: an update.
Durvasula RV; Shankland SJ
Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):1-7. PubMed ID: 16340659
[TBL] [Abstract][Full Text] [Related]
7. Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.
Oh J; Reiser J; Mundel P
Pediatr Nephrol; 2004 Feb; 19(2):130-7. PubMed ID: 14673634
[TBL] [Abstract][Full Text] [Related]
8. Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
Kawachi H; Suzuki K; Miyauchi N; Hashimoto T; Otaki Y; Shimizu F
Clin Exp Nephrol; 2009 Aug; 13(4):275-280. PubMed ID: 19266252
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of the podocyte in nephrotic syndrome.
Ding WY; Saleem MA
Kidney Res Clin Pract; 2012 Jun; 31(2):87-93. PubMed ID: 26889414
[TBL] [Abstract][Full Text] [Related]
10. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
11. Podocentric view of glomerular proteinuria: Focused on cytoskeletal changes and toward promising targeted therapies and challenges.
Kuo MC; Liang PI; Chang JM
Kaohsiung J Med Sci; 2021 Jul; 37(7):539-546. PubMed ID: 33942997
[TBL] [Abstract][Full Text] [Related]
12. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
[TBL] [Abstract][Full Text] [Related]
13. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
14. LIM and SH3 protein 1 (LASP-1): A novel link between the slit membrane and actin cytoskeleton dynamics in podocytes.
Lepa C; Möller-Kerutt A; Stölting M; Picciotto C; Eddy ML; Butt E; Kerjaschki D; Korb-Pap A; Vollenbröker B; Weide T; George B; Kremerskothen J; Pavenstädt H
FASEB J; 2020 Apr; 34(4):5453-5464. PubMed ID: 32086849
[TBL] [Abstract][Full Text] [Related]
15. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
Faul C; Asanuma K; Yanagida-Asanuma E; Kim K; Mundel P
Trends Cell Biol; 2007 Sep; 17(9):428-37. PubMed ID: 17804239
[TBL] [Abstract][Full Text] [Related]
16. Targeting signaling pathways in glomerular diseases.
Henique C; Tharaux PL
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):417-27. PubMed ID: 22660552
[TBL] [Abstract][Full Text] [Related]
17. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
[TBL] [Abstract][Full Text] [Related]
18. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
19. High-content screening assay-based discovery of paullones as novel podocyte-protective agents.
Lee HW; Arif E; Altintas MM; Quick K; Maheshwari S; Plezia A; Mahmood A; Reiser J; Nihalani D; Gupta V
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F280-F292. PubMed ID: 29046299
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-actin dynamics in health and disease.
Perico L; Conti S; Benigni A; Remuzzi G
Nat Rev Nephrol; 2016 Nov; 12(11):692-710. PubMed ID: 27573725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
